Patent · US Active

Cytomegalovirus inhibitor compounds

US9249158B2 · kind B2 · utility

2Cited by
0References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 3, 2013
Grant dateFeb 2, 2016
Priority date
Expiry dateApr 3, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.